Allergan Stock Buy Or Sell 【FRESH ◉】

: The Allergan division, now branded as Allergan Aesthetics , continues to lead the global medical aesthetics market with products like Botox.

Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue. allergan stock buy or sell

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq . : The Allergan division, now branded as Allergan

As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020. : The Allergan division